Fair Value Calculator Fair Value Calculator
EN DE

PROCLB (PROCLB) Fair Value & Analysis

IN · Market cap ₹138M

P PROCLB PROCLB · BSE
Price₹26.99
Fair Value₹13.34
Upside-50.6%
Quality61/100
Watch PROCLB for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹11.13 – ₹16.68

Fair value as of: Jul 5, 2026

From 20 valuation models · updated today

Share price −13.5% over the past month.

Price vs Fair Value (12 months)

₹47.90 ₹24.45 Fair Value ₹13.34 Jul 2025 Jul 2026

12‑month range ₹24.45 – ₹47.90 · fair‑value band ₹11.13 – ₹16.68 · the ₹26.99 price screens above the ₹13.34 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

PROCLB (PROCLB) currently trades at ₹26.99, while our model-based Fair Value estimate is ₹13.34 — implying the stock looks roughly 50.6% overvalued today. We read business quality at 61/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, PROCLB generated revenue of ₹11.5M at a net margin of 87.7%. It earns a return on equity of 9.5%. The stock trades on a trailing P/E of 13.7. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹11.13 (bear case) to ₹16.68 (bull case); at ₹26.99, the current price sits above that range. The share trades about 45% below its 52-week high and 16% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹11.5M
Revenue growth (YoY) +829,900%
Net margin 87.7%
Return on equity 9.5%
Free cash flow ₹37.0K FY2026
P/E ratio 13.7
More key figures
Operating margin 87.3%
EPS (TTM) ₹1.97
Net debt ₹809K FY2023

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

PROCLB reported revenue of ₹11.5M in FY2026 versus ₹15.6M in FY2022, a compound −7.4%/yr. Reported net income was ₹10.0M in FY2026.

Revenue −7.4%/yr
FY22 ₹15.6M
FY23 ₹993K
FY24 ₹3.6M
FY25 ₹0
FY26 ₹11.5M
Net income
FY22 −₹3.4M
FY23 −₹8.7M
FY24 ₹1.8M
FY25 −₹9.8M
FY26 ₹10.0M

Is PROCLB fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "PROCLB Fair Value". https://www.fairvalue-calculator.com/stock/PROCLB

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is PROCLB (PROCLB) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹13.34 versus a price of ₹26.99 — about −51% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PROCLB?
Our model-based fair value for PROCLB is ₹13.34 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹26.99.
What is the quality score of PROCLB?
PROCLB has a Quality Score of 61/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of PROCLB (PROCLB)?
PROCLB reported trailing-twelve-month revenue of about ₹11.5M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of PROCLB?
The net profit margin of PROCLB is about 87.7%, meaning it keeps roughly 87.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.